# Biochemical Recurrence Rate of Radical Prostatectomy Combined With Neoadjuvant and Adjuvant Chemotherapy in High Risk Prostate Cancer

> **NCT01530295** · NA · UNKNOWN · sponsor: **Hanjong Ahn** · enrollment: 70 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** DOCETAXEL

## Key facts

- **NCT ID:** NCT01530295
- **Lead sponsor:** Hanjong Ahn
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-07
- **Primary completion:** 2012-07
- **Final completion:** 2012-07
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2012-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01530295

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01530295, "Biochemical Recurrence Rate of Radical Prostatectomy Combined With Neoadjuvant and Adjuvant Chemotherapy in High Risk Prostate Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01530295. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*